FTY720 attenuates excitotoxicity and neuroinflammation

BACKGROUND: FTY720 (fingolimod, Gilenya™), a structural analog of sphingosine-1-phosphate (S1P), is the first oral drug approved for treatment the relapsing-remitting form of multiple sclerosis (MS), and its efficacy has been related to induced lymphopenia and consequent immunosuppression via modula...

Descripción completa

Detalles Bibliográficos
Autores principales: Cipriani, Raffaela, Chara, Juan Carlos, Rodríguez-Antigüedad, Alfredo, Matute, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429813/
https://www.ncbi.nlm.nih.gov/pubmed/25953296
http://dx.doi.org/10.1186/s12974-015-0308-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429813/
https://www.ncbi.nlm.nih.gov/pubmed/25953296
http://dx.doi.org/10.1186/s12974-015-0308-6

Ejemplares similares